FBXO5 and uterine cancer: Conversely, there is a wide range of FBXO5 alterations in uterine cancer that includes a serine to glycine conversion within the F-box motif (S278G), which could potentially impact protein–protein interactions with SKP1 and the rest of the SCF complex.